PLPPR3


Summary: The proteins in the lipid phosphate phosphatase (LPP) family, including PRG2, are integral membrane proteins that modulate bioactive lipid phosphates including phosphatidate, lysophosphatidate, and sphingosine-1-phosphate in the context of cell migration, neurite retraction, and mitogenesis (Brauer et al., 2003 [PubMed 12730698]).[supplied by OMIM, Mar 2008].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

GO terms in PLPPR3


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
MF IBA GO:0008195 phosphatidate phosphatase activity
MF IBA GO:0016791 phosphatase activity
MF IBA GO:0042577 lipid phosphatase activity
BP IBA GO:0006644 phospholipid metabolic process
BP IBA GO:0007165 signal transduction
BP IBA GO:0046839 phospholipid dephosphorylation
Showing 1 to 6 of 7 rows

Gene expression in normal tissue: PLPPR3

Gene-model tissue-cancer distribution: Bubble Plot

undefinetissue: undefine cancer: undefined model num: 0undefinedtissue: undefined cancer: PANCAN model num: 2

Gene-drug pathway distribution

ERK MAPK signaling1

Pathways in PLPPR3


Loading, please wait...
Database
Pathway ID
Pathway Des.
humancyc TRIGLSYN-PWY triacylglycerol biosynthesis
reactome R-HSA-162582 Signal Transduction
reactome R-HSA-372790 Signaling by GPCR
reactome R-HSA-373076 Class A/1 (Rhodopsin-like receptors)
reactome R-HSA-419408 Lysosphingolipid and LPA receptors
reactome R-HSA-500792 GPCR ligand binding
Showing 1 to 6 of 6 rows

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD353 PD0325901 2
Showing 1 to 1 of 1 rows

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in PLPPR3

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​